SCHEMBL6760159

SCHEMBL6760159

CC(C)(C)OC(=O)NCCSc1nccc(Cl)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STK17B O94768 1/20 0.47
▸ STK17A Q9UEE5 1/20 0.47
▸ IDO1 P14902 3/20 0.45
▸ LMNA P02545 3/20 0.42
▸ HPGD P15428 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ ATR Q13535 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ HTT P42858 1/20 0.39
▸ CA12 O43570 3/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39
▸ CA9 Q16790 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31490568 0.84 IDO1 (0.48) STK17BSTK17AIDO1LMNAHPGD
SCHEMBL6757788 0.81 POLB (0.38) STK17BSTK17AIDO1LMNAHPGD
SCHEMBL17564551 0.80 STK17B (0.46) STK17BSTK17AIDO1LMNAHPGD
SCHEMBL14907944 0.77 BCHE (0.49) STK17BSTK17AATRBCHEKDM4E
SCHEMBL6762409 0.77 IDO1 (0.44) STK17BSTK17AIDO1LMNAHPGD
SCHEMBL10258684 0.75 NPSR1 (0.42) STK17BSTK17AIDO1LMNAGAA
SCHEMBL14907974 0.75 STK17B (0.59) STK17BSTK17AGAAMEN1KMT2A
SCHEMBL10493769 0.75 IDO1 (0.46) IDO1LMNAGAAALDH1A1SMN1; SMN2
SCHEMBL16410303 0.75 ATR (0.47) STK17BSTK17ALMNAGAAMEN1
SCHEMBL7866002 0.74 IDO1 (0.47) STK17BSTK17AIDO1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723716-B1 BACTERICIDE FOR STAPHYLOCOCCUS ESSENTIAL THERAPEUTICS, INC. 2004-04-20 — — US disclosed
EP-1222194-A1 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID ANTIBIOTICS AND PRODRUGS THEREOF Essential Therapeutics, Inc. (US) 2002-07-17 — — EP disclosed
WO-2001021623-A1 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID ANTIBIOTICS AND PRODRUGS THEREOF ESSENTIAL THERAPEUTICS, INC. (US) 2001-03-29 — — WO disclosed
Send feedback